1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease

American Journal of Hematology

Volumn 51, Issue 2, 1996, Pages 158-163

  McKeown, L P ^a   Connaghan, G ^a   Wilson, O ^a   Hansmann, K ^a   Merryman, P ^a   Gralnick, H R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

DDAVP; Thrombocytopenia; Type 2B von Willebrand's disease

Indexed keywords

CITRATE SODIUM; DESMOPRESSIN; DESMOPRESSIN ACETATE; EDETIC ACID; HEPARIN LITHIUM; OXALATE SODIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ADULT; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RENAL AGENTS; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

EID: 0030059702     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199602)51:2<158::AID-AJH11>3.0.CO;2-E     Document Type: Article

References (33)

1. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A: DDAVP. A new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1:869, 1977.
2. Mannucci PM: Desmopressin (DDAVP) for treatment of disorders of hemostasis. Progress Hemost Thromb 8:19, 1986.
3. Gralnick HR, Williams SB, McKeown LP, Shafer BC, Rick ME: Platelet von Willebrand factor: Comparison with plasma von Willebrand factor. Thromb Res 38:623, 1985.
4. Mannucci PM: Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 72:1449, 1988.
5. Mariani G, Ciavarella N, Mazzucconi MG: Effectiveness of DDAVP in surgery and bleeding episodes in haemophilia and von Willebrand's disease: A study on 43 patients. Clin Lab Haematol 6:229, 1984.
6. De La Fuente B, Kasper CK, Rickles FR, Hoyer LW: Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Int Med 103:6, 1985.
7. Batlle J, Lopez Fernandez MF, Campos M, Justica B, Borges C, Navarro JL, Diaz Cremades JM, Kasper CR, Dent JA, Ruggeri ZM, Zimmerman TS: The heterogeneity of type IIA von Willebrand's disease: Studies with protease inhibitors. Blood 68:1207, 1986.
8. Gralnick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y: DDAVP in type IIA von Willebrand's disease. Blood 67:465, 1986
9. Holmberg L, Nilsson IM, Borge L, Gunnarson M, Sjorin E: Platelet aggregation induced by 1-desamino-8-D-arginine-vasopressin (DDAVP) in type IIB von Willebrand's disease. N Eng J Med 309:816, 1983
10. Holmberg L, Nilsson IM: von Willebrand's disease. Eur J Haematol 48:127, 1992.
11. Kyrie PA, Niessner H, Dent J, Panzer S, Brenner B, Zimmerman TS, Lechner K: IIB von Willebrand's disease: Pathogenetic and therapeutic studies. Br J Haematol 69:55, 1988.
12. Casonato A, Fabris F, Girolami A: Platelet aggregation and pseudothiombocytopenia induced by 1-desamino-8-D-arginine-vasopressin (DDAVP) in type IIB. Eur J Haematol 45:36, 1990.
13. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS: Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 59:1272, 1982.
14. Cooney KA, Nichols WC, Bruck ME, Bahou WF, Shapiro AD, Bowie GWF, Gralnick HR, Ginsburg D: The molecular defect in type IIB von Willebrand Disease. J Clin Inves 87:1227, 1991
15. O'Brien JR, Green PJ, Salmon G, Weir P, Colin-Jones D, Arnold M, Chopra S: Desmopressin and myocardial infarction. Lancet 1:664, 1989.
16. van Dantzig JM, Duren DR, Ten Cate JW: Intravenous desmopressin enhances factor VIII procoagulant, von Willebrand factor, and tissue plasminogen activator (tPA) activity levels in plasma. Lancet 1:664, 1989.
17. Editorial: Desmopressin and arterial thrombosis. Lancet 1:938, 1989.
18. Mannucci PM, Lusher JM: Desmopressin and thrombosis. Lancet 1:675, 1989.
19. Ginsburg D, Sadler JE: von Willebrand's disease: A database of point mutations, insertions and deletions. Thromb Haemost 2:177, 1993.
20. Donner M, Kristoffersson AC, Lenk H: Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families, from Denmark, Germany and Sweden. Br J Haematol 82:58, 1992.
21. Piao YC, Lavergne JM, Boyer-Neumann C, Schlandelong A, Alessi MC, Meyer D: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease. Blood Coag Fibrinol 4:787, 1993.
22. Lillicrap D, Murray EW, Benford K: Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease. Br J Haematol 79:612, 1991.
23. 545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease. Eur J Haematol 47:342, 1991.
24. Murray EW, Giles AR, Lillicrap D: Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIb von Willebrand disease Am J Hum Genet 50:199, 1992.
25. 578-Gln. J Biol Chem 267:21187, 1992.
26. Inbal A, Kornbrot N, Randi A, Sadler JE: Effect of type lib von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding-studies with recombinant von Willebrand factor Thromb Hemost 70:1058, 1993.
27. Kroner PA, Kluessendorf ML, Scott JP, Montgomery RR: Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets. Blood 79:2048, 1992.
28. Fowler WE, Berkowitz LR, Roberts HR: DDAVP for type IIb von Willebrand disease. Blood 74:1859, 1989.
29. Sakariassen K, Cattaneo M, v.d. Berg A, Ruggeri ZM, Manucci PM, Sixma JJ: DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 64:229, 1984.
30. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI: von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Inves 88:1568, 1991.
31. Cattaneo M, Lombardi R, Bettega D, Lecchi A, Manucci P: Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidane. Arteriosclerosis Thromb 13:393, 1992.
32. Murata M, Fukuyama M, Satoh K: Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type lib and platelet-type von Willebrand disease. J Clin Invest 92:1555, 1993.
33. Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, Ruggeri AM: Trans-membrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost 69:496, 1993.